News Focus
News Focus
Followers 22
Posts 4648
Boards Moderated 0
Alias Born 01/27/2022

Re: rosemountbomber post# 434481

Monday, 03/31/2025 10:16:24 AM

Monday, March 31, 2025 10:16:24 AM

Post# of 447294
RMB, got it. I assumed you were referring to Denner's work with Amarin.

As far as Amarin's circumstances, I actually DO believe that Amarin would be in the same, or better position with prior management.

Sarissa has INTENTIONALLY withheld support of the stock price, AND gone dark from a marketing/PR perspective. They have literally gone silent for 18+ months while the stock price has crumbled. And most of what has occurred operationally was already in motion when they took over (country approvals, rollouts, etc.).

The only positive I can point to with Sarissa is the swiftness and depth of their cost cutting. But at the same time, I do feel that some of the cuts and personnel decisions are foolhardy. The CEO position is a perfect example. I don't believe Aaron Berg has the depth of experience or skill to be CEO of this company. Obviously, they believe that he is simply CEO in name only; a figurehead. Sarissa is doing to real decision-making.

The comment about seeing into the future was concerning the Bioverativ litigatiion.
If you don't think Amarin would be in this same position or worse with prior management I don't know what to tell you.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News